Book contents
- Treatment-Related StrokeIncluding Iatrogenic and In-hospital Strokes
- Treatment-Related Stroke
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Section I Iatrogenic ischemic strokes: peri- and postoperative strokes
- Section II Iatrogenic ischemic strokes: stroke after endovascular procedures
- Section III Iatrogenic ischemic strokes: other causes
- Section IV Iatrogenic hemorrhagic strokes: thrombolysis-related hemorrhagic strokes
- Section V Iatrogenic hemorrhagic strokes: intracranial bleeding
- Section VI Iatrogenic hemorrhagic strokes: anticoagulation-related intracranial hemorrhage
- Section VII Other uncommon causes of iatrogenic stroke
- Section VIII Cerebral venous thrombosis
- Section IX Medication reversal and restarting in patients with iatrogenic strokes
- Index
- References
Section II - Iatrogenic ischemic strokes: stroke after endovascular procedures
Published online by Cambridge University Press: 20 October 2016
Book contents
- Treatment-Related StrokeIncluding Iatrogenic and In-hospital Strokes
- Treatment-Related Stroke
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Section I Iatrogenic ischemic strokes: peri- and postoperative strokes
- Section II Iatrogenic ischemic strokes: stroke after endovascular procedures
- Section III Iatrogenic ischemic strokes: other causes
- Section IV Iatrogenic hemorrhagic strokes: thrombolysis-related hemorrhagic strokes
- Section V Iatrogenic hemorrhagic strokes: intracranial bleeding
- Section VI Iatrogenic hemorrhagic strokes: anticoagulation-related intracranial hemorrhage
- Section VII Other uncommon causes of iatrogenic stroke
- Section VIII Cerebral venous thrombosis
- Section IX Medication reversal and restarting in patients with iatrogenic strokes
- Index
- References
- Type
- Chapter
- Information
- Treatment-Related StrokeIncluding Iatrogenic and In-Hospital Strokes, pp. 63 - 112Publisher: Cambridge University PressPrint publication year: 2016
References
References
Alberts, M J, Brass, L M, Perry, A, Webb, D, Dawson, D V. Evaluation times for patients with in-hospital strokes. Stroke. 1993; 24:1817–22.
Emiru, T, Adil, M M, Suri, M F, Qureshi, A I. Thrombolytic treatment for in-hospital ischemic strokes in United States. Journal of Vascular and Interventional Neurology. 2014; 7:28–34.
Kelley, R E, Kovacs, A G. Mechanism of in-hospital cerebral ischemia. Stroke. 1986; 17:430–3.
Barnwell, S L, Clark, W M, Nguyen, T T, et al. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. American Journal of Neuroradiology. 1994; 15:1817–22.
Bavinzski, G, Killer, M, Ferraz-Leite, H, et al. Endovascular therapy of idiopathic cavernous aneurysms over 11 years. American Journal of Neuroradiology. 1998; 19:559–65.
Belan, A, Vesela, M, Vanek, I, Weiss, K, Peregrin, J H. Percutaneous transluminal angioplasty of fibromuscular dysplasia of the internal carotid artery. Cardiovascular and Interventional Radiology. 1982; 5:79–81.
Benati, A. Interventional neuroradiology for the treatment of inaccessible arterio-venous malformations. Acta Neurochirurgica. 1992; 118:76–9.
Brown, M M, Butler, P, Gibbs, J, Swash, M, Waterston, J. Feasibility of percutaneous transluminal angioplasty for carotid artery stenosis. Journal of Neurology, Neurosurgery, and Psychiatry. 1990; 53:238–43.
Casasco, A E, Aymard, A, Gobin, Y P, et al. Selective endovascular treatment of 71 intracranial aneurysms with platinum coils. Journal of Neurosurgery. 1993; 79:3–10.
Cognard, C, Weill, A, Castaings, L, Rey, A, Moret, J. Intracranial berry aneurysms: Angiographic and clinical results after endovascular treatment. Radiology. 1998; 206:499–510.
Crawley, F, Clifton, A, Buckenham, T, et al. Comparison of hemodynamic cerebral ischemia and microembolic signals detected during carotid endarterectomy and carotid angioplasty. Stroke. 1997; 28:2460–4.
Crawley, F, Clifton, A, Markus, H, Brown, M M. Delayed improvement in carotid artery diameter after carotid angioplasty. Stroke. 1997; 28:574–9.
Criado, F J, Wellons, E, Clark, N S. Evolving indications for and early results of carotid artery stenting. American Journal of Surgery. 1997; 174:111–14.
Cronqvist, M, Pierot, L, Boulin, A, et al. Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracerebral aneurysm: A comparison of anatomic results and clinical outcome. American Journal of Neuroradiology. 1998; 19:157–65.
Debrun, G, Vinuela, F, Fox, A, Drake, C G. Embolization of cerebral arteriovenous malformations with bucrylate. Journal of Neurosurgery. 1982; 56:615–27.
Debrun, G M, Aletich, V, Ausman, J I, Charbel, F, Dujovny, M. Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery. 1997; 40:112–20.
Debrun, G M, Aletich, V A, Kehrli, P, et al. Selection of cerebral aneurysms for treatment using Guglielmi detachable coils: The preliminary University of Illinois at Chicago experience. Neurosurgery. 1998; 43:1281–95.
Diethrich, E B, Ndiaye, M, Reid, D B. Stenting in the carotid artery: Initial experience in 110 patients. Journal of Endovascular Surgery. 1996; 3:42–62.
Dion, J E, Gates, P C, Fox, A J, Barnett, H J, Blom, R J. Clinical events following neuroangiography: A prospective study. Stroke. 1987; 18:997–1004.
Earnest, F T, Forbes, G, Sandok, B A, et al. Complications of cerebral angiography: Prospective assessment of risk. American Journal of Roentgenology. 1984; 142:247–53.
Endo, S, Kuwayama, N, Hirashima, Y, et al. Results of urgent thrombolysis in patients with major stroke and atherothrombotic occlusion of the cervical internal carotid artery. American Journal of Neuroradiology. 1998; 19:1169–75.
Fournier, D, TerBrugge, K G, Willinsky, R, Lasjaunias, P, Montanera, W. Endovascular treatment of intracerebral arteriovenous malformations: Experience in 49 cases. Journal of Neurosurgery. 1991; 75:228–33.
Fox, A J, Pelz, D M, Lee, D H. Arteriovenous malformations of the brain: Recent results of endovascular therapy. Radiology. 1990; 177:51–7.
Freitag, G, Freitag, J, Koch, R D, Wagemann, W. Percutaneous angioplasty of carotid artery stenoses. Neuroradiology. 1986; 28:126–7.
Frey, J L, Greene, K A, Khayata, M H, et al. Intrathrombus administration of tissue plasminogen activator in acute cerebrovascular occlusion. Angiology. 1995; 46:649–56.
Gil-Peralta, A, Mayol, A, Marcos, J R, et al. Percutaneous transluminal angioplasty of the symptomatic atherosclerotic carotid arteries. Results, complications, and follow-up. Stroke. 1996; 27:2271–3.
Gobin, Y P, Laurent, A, Merienne, L, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. Journal of Neurosurgery. 1996; 85:19–28.
Graves, V B, Strother, C M, Duff, T A, Perl, J 2nd. Early treatment of ruptured aneurysms with Guglielmi detachable coils: Effect on subsequent bleeding. Neurosurgery. 1995; 37:640–7.
Guglielmi, G, Vinuela, F, Duckwiler, G, et al. Endovascular treatment of posterior circulation aneurysms by electrothrombosis using electrically detachable coils. Journal of Neurosurgery. 1992; 77:515–24.
Gurian, J H, Martin, N A, King, W A, et al. Neurosurgical management of cerebral aneurysms following unsuccessful or incomplete endovascular embolization. Journal of Neurosurgery. 1995; 83:843–53.
Guterman, L R, Budny, J L, Gibbons, K J, Hopkins, L N. Thrombolysis of the cervical internal carotid artery before balloon angioplasty and stent placement: Report of two cases. Neurosurgery. 1996; 38:620–3.
Heiserman, J E, Dean, B L, Hodak, J A, et al. Neurologic complications of cerebral angiography. American Journal of Neuroradiology. 1994; 15:1401–7.
Henry, M, Amor, M, Masson, I, et al. Angioplasty and stenting of the extracranial carotid arteries. Journal of Endovascular Surgery. 1998; 5:293–304.
Heras, M, Chesebro, J H, Penny, W J, et al. Importance of adequate heparin dosage in arterial angioplasty in a porcine model. Circulation. 1988; 78:654–60.
Higashida, R T, Halbach, V V, Barnwell, S L, et al. Treatment of intracranial aneurysms with preservation of the parent vessel: Results of percutaneous balloon embolization in 84 patients. American Journal of Neuroradiology. 1990; 11:633–40.
Higashida, R T, Halbach, V V, Cahan, L D, Hieshima, G B, Konishi, Y. Detachable balloon embolization therapy of posterior circulation intracranial aneurysms. Journal of Neurosurgery. 1989; 71:512–19.
Higashida, R T, Halbach, V V, Dowd, C, et al. Endovascular detachable balloon embolization therapy of cavernous carotid artery aneurysms: Results in 87 cases. Journal of Neurosurgery. 1990; 72:857–63.
Higashida, R T, Halbach, V V, Dowd, C F, Barnwell, S L, Hieshima, G B. Intracranial aneurysms: Interventional neurovascular treatment with detachable balloons – results in 215 cases. Radiology. 1991; 178:663–70.
Hodes, J E, Aymard, A, Gobin, Y P, et al. Endovascular occlusion of intracranial vessels for curative treatment of unclippable aneurysms: Report of 16 cases. Journal of Neurosurgery. 1991; 75:694–701.
Huang, Z, Dai, Q, Suo, J, et al. Percutaneous endovascular embolization of intracerebral arteriovenous malformations. Experience in 72 cases. Chinese Medical Journal. 1995; 108:413–19.
Jordan, W D Jr., Schroeder, P T, Fisher, W S, McDowell, H A. A comparison of angioplasty with stenting versus endarterectomy for the treatment of carotid artery stenosis. Annals of Vascular Surgery. 1997; 11:2–8.
Jordan, W D Jr., Voellinger, D C, Doblar, D D, et al. Microemboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. Cardiovascular Surgery. 1999; 7:33–8.
Kachel, R, Basche, S, Heerklotz, I, Grossmann, K, Endler, S. Percutaneous transluminal angioplasty (PTA) of supra-aortic arteries especially the internal carotid artery. Neuroradiology. 1991; 33:191–4.
Kachel, R, Endert, G, Basche, S, Grossmann, K, Glaser, F H. Percutaneous transluminal angioplasty (dilatation) of carotid, vertebral, and innominate artery stenoses. Cardiovascular and Interventional Radiology. 1987; 10:142–6.
Kearon, C, Hirsh, J. Management of anticoagulation before and after elective surgery. New England Journal of Medicine. 1997; 336:1506–11.
Kesava, P, Graves, V, Salamat, S, Rappe, A. Intraarterial thrombolysis in a pig model: A preliminary note. American Journal of Neuroradiology. 1997; 18:915–20.
Klein, G E, Szolar, D H, Leber, K A, Karaic, R, Hausegger, K A. Basilar tip aneurysm: Endovascular treatment with Guglielmi detachable coils – midterm results. Radiology. 1997; 205:191–6.
Klotzsch, C, Nahser, H C, Henkes, H, Kuhne, D, Berlit, P. Detection of microemboli distal to cerebral aneurysms before and after therapeutic embolization. American Journal of Neuroradiology. 1998; 19:1315–18.
Koenigsberg, R A, Wysoki, M, Weiss, J, Faro, S H, Tsai, F Y. Risk of clot formation in femoral arterial sheaths maintained overnight for neuroangiographic procedures. American Journal of Neuroradiology. 1999; 20:297–9.
Krupski, W C, Bass, A, Kelly, A B, Hanson, S R, Harker, L A. Reduction in thrombus formation by placement of endovascular stents at endarterectomy sites in baboon carotid arteries. Circulation. 1991; 84:1749–57.
Kuether, T A, Nesbit, G M, Barnwell, S L. Clinical and angiographic outcomes, with treatment data, for patients with cerebral aneurysms treated with Guglielmi detachable coils: A single-center experience. Neurosurgery. 1998; 43:1016–25.
Lagalla, G, Ceravolo, M G, Provinciali, L, et al. Transcranial Doppler sonographic monitoring during cerebral aneurysm embolization: A preliminary report. American Journal of Neuroradiology. 1998; 19:1549–53.
Lam, J Y, Chesebro, J H, Steele, P M, et al. Deep arterial injury during experimental angioplasty: Relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. Journal of the American College of Cardiology. 1986; 8:1380–6.
Larson, J J, Tew, J M Jr., Tomsick, T A, van Loveren, H R. Treatment of aneurysms of the internal carotid artery by intravascular balloon occlusion: Long-term follow-up of 58 patients. Neurosurgery. 1995; 36:26–30.
Lincoff, A M, Tcheng, J E, Califf, R M, et al. Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG investigators. American Journal of Cardiology. 1997; 79:286–91.
Lundqvist, C, Wikholm, G, Svendsen, P. Embolization of cerebral arteriovenous malformations: Part II – aspects of complications and late outcome. Neurosurgery. 1996; 39:460–7.
Malisch, T W, Guglielmi, G, Vinuela, F, et al. Intracranial aneurysms treated with the Guglielmi detachable coil: Midterm clinical results in a consecutive series of 100 patients. Journal of Neurosurgery. 1997; 87:176–83.
Markus, H S, Clifton, A, Buckenham, T, Brown, M M. Carotid angioplasty. Detection of embolic signals during and after the procedure. Stroke. 1994; 25:2403–6.
Markus, H S, Clifton, A, Buckenham, T, Taylor, R, Brown, M M. Improvement in cerebral hemodynamics after carotid angioplasty. Stroke. 1996; 27:612–16.
Mathur, A, Roubin, G S, Gomez, C R, et al. Elective carotid artery stenting in the presence of contralateral occlusion. American Journal of Cardiology. 1998; 81:1315–17.
Mathur, A, Roubin, G S, Iyer, S S, et al. Predictors of stroke complicating carotid artery stenting. Circulation. 1998; 97:1239–45.
McDougall, C G, Halbach, V V, Dowd, C F, et al. Treatment of basilar tip aneurysms using electrolytically detachable coils. Journal of Neurosurgery. 1996; 84:393–9.
Mericle, R A, Lanzino, G, Wakhloo, A K, Guterman, L R, Hopkins, L N. Stenting and secondary coiling of intracranial internal carotid artery aneurysm: Technical case report. Neurosurgery. 1998; 43:1229–34.
Merland, J J, Rufenacht, D, Laurent, A, Guimaraens, L. Endovascular treatment with isobutyl cyano acrylate in patients with arteriovenous malformation of the brain. Indications, results and complications. Acta Radiologica. Supplementum. 1986; 369:621–2.
Moret, J, Pierot, L, Boulin, A, Castaings, L, Rey, A. Endovascular treatment of anterior communicating artery aneurysms using Guglielmi detachable coils. Neuroradiology. 1996; 38:800–5.
Munari, L M, Belloni, G, Perretti, A, et al. Carotid percutaneous angioplasty. Neurological Research. 1992; 14:156–8.
Nakstad, P H, Nornes, H. Superselective angiography, embolisation and surgery in treatment of arteriovenous malformations of the brain. Neuroradiology. 1994; 36:410–13.
Nesbit, G M, Clark, W M, O’Neill, O R, Barnwell, S L. Intracranial intraarterial thrombolysis facilitated by microcatheter navigation through an occluded cervical internal carotid artery. Journal of Neurosurgery. 1996; 84:387–92.
Nichols, D A, Brown, R D Jr., Thielen, K R, et al. Endovascular treatment of ruptured posterior circulation aneurysms using electrolytically detachable coils. Journal of Neurosurgery. 1997; 87:374–80.
Pasqualin, A, Scienza, R, Cioffi, F, et al. Treatment of cerebral arteriovenous malformations with a combination of preoperative embolization and surgery. Neurosurgery. 1991; 29:358–68.
Pelz, D M, Lownie, S P, Fox, A J. Thromboembolic events associated with the treatment of cerebral aneurysms with Guglielmi detachable coils. American Journal of Neuroradiology. 1998; 19:1541–7.
Pierot, L, Boulin, A, Castaings, L, Rey, A, Moret, J. Selective occlusion of basilar artery aneurysms using controlled detachable coils: Report of 35 cases. Neurosurgery. 1996; 38:948–53.
Raschke, R A, Reilly, B M, Guidry, J R, Fontana, J R, Srinivas, S. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial. Annals of Internal Medicine. 1993; 119:874–81.
Raymond, J, Roy, D. Safety and efficacy of endovascular treatment of acutely ruptured aneurysms. Neurosurgery. 1997; 41:1235–45.
Raymond, J, Roy, D, Bojanowski, M, Moumdjian, R, L’Esperance, G. Endovascular treatment of acutely ruptured and unruptured aneurysms of the basilar bifurcation. Journal of Neurosurgery. 1997; 86:211–19.
Raymond, J, Theron, J. Intracavernous aneurysms: Treatment by proximal balloon occlusion of the internal carotid artery. American Journal of Neuroradiology. 1986; 7:1087–92.
Rich, L F, Weimar, V L, Squires, E L, Haraguchi, K H. Stimulation of corneal wound healing with mesodermal growth factor. Archives of Ophthalmology. 1979; 97:1326–30.
Roubin, G S, Yadav, S, Iyer, S S, Vitek, J. Carotid stent-supported angioplasty: A neurovascular intervention to prevent stroke. American Journal of Cardiology. 1996; 78:8–12.
Rowe, J G, Byrne, J V, Molyneux, A, Rajagopalan, B. Haemodynamic consequences of embolizing aneurysms: A transcranial Doppler study. British Journal of Neurosurgery. 1995; 9:749–57.
Rowe, J G, Molyneux, A J, Byrne, J V, Renowden, S, Aziz, T Z. Endovascular treatment of intracranial aneurysms: A minimally invasive approach with advantages for elderly patients. Age and Ageing. 1996; 25:372–6.
Sawyer, P N, Stanczewski, B, Pomerance, A, Stoner, G, Srinivasan, S. Utility of anticoagulant drugs in vascular thrombosis: Electron microscopic and biophysical study. Surgery. 1973; 74:263–75.
Scarborough, R M, Rose, J W, Hsu, M A, et al. Barbourin. A GPIIB-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. Journal of Biological Chemistry. 1991; 266:9359–62.
Schatz, R A, Baim, D S, Leon, M, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation. 1991; 83:148–61.
Schlossman, D. Thrombogenic properties of vascular catheter materials in vivo. The differences between materials. Acta Radiologica: Diagnosis. 1973; 14:186–92.
Schomig, A, Neumann, F J, Kastrati, A, al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. New England Journal of Medicine. 1996; 334:1084–9.
Schumacher, M, Horton, J A. Treatment of cerebral arteriovenous malformations with PVA. Results and analysis of complications. Neuroradiology. 1991; 33:101–5.
Segi, E, Sugimoto, Y, Yamasaki, A, et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochemical and Biophysical Research Communications. 1998; 246:7–12.
Serbinenko, F A. Balloon catheterization and occlusion of major cerebral vessels. Journal of Neurosurgery. 1974; 41:125–45.
Serruys, P W, de Jaegere, P, Kiemeneij, F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent study group. New England Journal of Medicine. 1994; 331:489–95.
Sharis, P J, Cannon, C P, Loscalzo, J. The antiplatelet effects of ticlopidine and clopidogrel. Annals of Internal Medicine. 1998; 129:394–405.
Smedema, J P, Saaiman, A. Carotid stent-assisted angioplasty. South African Medical Journal. 1997; 87 Suppl 1:C9–14.
Smith, D C, Smith, L L, Hasso, A N. Fibromuscular dysplasia of the internal carotid artery treated by operative transluminal balloon angioplasty. Radiology. 1985; 155:645–8.
Smyth, S S, Joneckis, C C, Parise, L V. Regulation of vascular integrins. Blood. 1993; 81:2827–43.
Sobel, M, McNeill, P M, Carlson, P L, et al. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. Journal of Clinical Investigation. 1991; 87:1787–93.
Speidel, C M, Eisenberg, P R, Ruf, W, Edgington, T S, Abendschein, D R. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. Circulation. 1995; 92:3323–30.
Spetzler, R F, Martin, N A, Carter, L P, et al. Surgical management of large AVM’s by staged embolization and operative excision. Journal of Neurosurgery. 1987; 67:17–28.
Stormorken, H. Effects of contrast media on the hemostatic and thrombotic mechanisms. Investigative Radiology. 1988; 23 Suppl 2:S318–25.
Taki, W, Nishi, S, Yamashita, K, et al. Selection and combination of various endovascular techniques in the treatment of giant aneurysms. Journal of Neurosurgery. 1992; 77:37–42.
Teitelbaum, G P, Lefkowitz, M A, Giannotta, S L. Carotid angioplasty and stenting in high-risk patients. Surgical Neurology. 1998; 50:300–11.
Theodotou, B C, Whaley, R, Mahaley, M S. Complications following transfemoral cerebral angiography for cerebral ischemia. Report of 159 angiograms and correlation with surgical risk. Surgical Neurology. 1987; 28:90–2.
Theron, J, Courtheoux, P, Alachkar, F, Bouvard, G, Maiza, D. New triple coaxial catheter system for carotid angioplasty with cerebral protection. American Journal of Neuroradiology. 1990; 11:869–74.
Theron, J G, Payelle, G G, Coskun, O, Huet, H F, Guimaraens, L. Carotid artery stenosis: Treatment with protected balloon angioplasty and stent placement. Radiology. 1996; 201:627–36.
Theroux, P. Antiplatelet therapy: Do the new platelet inhibitors add significantly to the clinical benefits of aspirin? American Heart Journal. 1997; 134:S62–70.
Theroux, P, Waters, D, Lam, J, Juneau, M, McCans, J. Reactivation of unstable angina after the discontinuation of heparin. New England Journal of Medicine. 1992; 327:141–5.
Thielen, K R, Nichols, D A, Fulgham, J R, Piepgras, D G. Endovascular treatment of cerebral aneurysms following incomplete clipping. Journal of Neurosurgery. 1997; 87:184–9.
Topol, E J. Ultrathrombolysis. Journal of the American College of Cardiology. 1990; 15:922–4.
Topol, E J, Bonan, R, Jewitt, D, et al. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. Circulation. 1993; 87:1622–9.
Touho, H. Percutaneous transluminal angioplasty in the treatment of atherosclerotic disease of the anterior cerebral circulation and hemodynamic evaluation. Journal of Neurosurgery. 1995; 82:953–60.
Tournade, A, Courtheoux, P, Sengel, C, Ozgulle, S, Tajahmady, T. Saccular intracranial aneurysms: Endovascular treatment with mechanical detachable spiral coils. Radiology. 1997; 202:481–6.
Tsai, F Y, Matovich, V, Hieshima, G, et al. Percutaneous transluminal angioplasty of the carotid artery. American Journal of Neuroradiology. 1986; 7:349–58.
Turpie, A G. Successors to heparin: New antithrombotic agents. American Heart Journal. 1997; 134:S71–77.
Van Belle, E, Tio, F O, Chen, D, et al. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. Journal of the American College of Cardiology. 1997; 29:1371–9.
Vinuela, F, Dion, J E, Duckwiler, G, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: Experience with 101 cases. Journal of Neurosurgery. 1991; 75:856–64.
Vinuela, F, Duckwiler, G, Mawad, M. Guglielmi detachable coil embolization of acute intracranial aneurysm: Perioperative anatomical and clinical outcome in 403 patients. Journal of Neurosurgery. 1997; 86:475–82.
Vorchheimer, D A, Badimon, JJ, Fuster, V. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. JAMA. 1999; 281:1407–14.
Vozzi, C R, Rodriguez, A O, Paolantonio, D, Smith, J A, Wholey, M H. Extracranial carotid angioplasty and stenting. Initial results and short-term follow-up. Texas Heart Institute Journal. 1997; 24:167–72.
Waigand, J, Gross, C M, Uhlich, F, et al. Elective stenting of carotid artery stenosis in patients with severe coronary artery disease. European Heart Journal. 1998; 19:1365–70.
Wallace, R C, Flom, R A, Khayata, M H, et al. The safety and effectiveness of brain arteriovenous malformation embolization using acrylic and particles: The experiences of a single institution. Neurosurgery. 1995; 37:606–15.
Wardlaw, J M, Warlow, C P, Counsell, C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet. 1997; 350:607–14.
Warkentin, T E, Levine, M N, Hirsh, J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. New England Journal of Medicine. 1995; 332:1330–5.
Weitz, J I. Low-molecular-weight heparins. New England Journal of Medicine. 1997; 337:688–98.
Weitz, J I, Hudoba, M, Massel, D, Maraganore, J, Hirsh, J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. Journal of Clinical Investigation. 1990; 86:385–91.
Wholey, M H, Wholey, M H, Jarmolowski, C R, et al. Endovascular stents for carotid artery occlusive disease. Journal of Endovascular Surgery. 1997; 4:326–38.
Wikholm, G, Lundqvist, C, Svendsen, P. Embolization of cerebral arteriovenous malformations: Part I – technique, morphology, and complications. Neurosurgery. 1996; 39:448–57.
Wityk, R J, Pessin, M S, Kaplan, R F, Caplan, L R. Serial assessment of acute stroke using the NIH stroke scale. Stroke. 1994; 25:362–5.
Yadav, J S, Roubin, G S, King, P, Iyer, S, Vitek, J. Angioplasty and stenting for restenosis after carotid endarterectomy. Initial experience. Stroke. 1996; 27:2075–9.
Yakes, W F, Krauth, L, Ecklund, J, et al. Ethanol endovascular management of brain arteriovenous malformations: Initial results. Neurosurgery. 1997; 40:1145–52.
Yalamanchili, K, Rosenwasser, R H, Thomas, J E, et al. Frequency of cerebral vasospasm in patients treated with endovascular occlusion of intracranial aneurysms. American Journal of Neuroradiology. 1998; 19:553–8.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996; 348:1329–39.
Ansara, A J, Shiltz, D L, Slavens, J B. Use of cilostazol for secondary stroke prevention: An old dog with new tricks? Annals of Pharmacotherapy. 2012; 46:394–402.
Gotoh, F, Tohgi, H, Hirai, S, et al. Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction. Journal of Stroke and Cerebrovascular Diseases. 2000; 9:147–57.
Dinicolantonio, J J, Lavie, C J, Fares, H, et al. Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke. American Journal of Cardiology. 2013; 112:1230–4.
Kamal, A K, Naqvi, I, Husain, M R, Khealani, B A. Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. Cochrane Database of Systematic Reviews. 2011; CD008076.
Ikeda, Y. Antiplatelet therapy using cilostazol, a specific PPE3 inhibitor. Thrombosis and Haemostasis. 1999; 82:435–8.
Jeng, J S, Sun, Y, Lee, J T, et al. The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): Protocol of a randomized, double-blind, placebo-controlled multicenter trial. International Journal of Stroke. 2015; 10:123–7.
Lefkovits, J, Plow, E F, Topol, E J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. New England Journal of Medicine. 1995; 332:1553–9.
PRISM-PLUS study investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet receptor inhibition in ischemic syndrome management in patients limited by unstable signs and symptoms (PRISM-PLUS). New England Journal of Medicine. 1998; 338:1488–97.
Ciccone, A, Motto, C, Abraha, I, Cozzolino, F, Santilli, I. Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke. Cochrane Database of Systematic Reviews. 2014; 3:CD005208.
Adams, H P Jr., Effron, M B, Torner, J, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: Results of an international phase III trial: Abciximab in emergency treatment of stroke trial (ABESTT-II). Stroke. 2008; 39:87–99.
Velat, G J, Burry, M V, Eskioglu, E, et al. The use of abciximab in the treatment of acute cerebral thromboembolic events during neuroendovascular procedures. Surgical Neurology. 2006; 65:352–8.
Siebler, M, Hennerici, M G, Schneider, D, et al. Safety of tirofiban in acute ischemic stroke: The SATIS trial. Stroke. 2011; 42:2388–92.
Kellert, L, Hametner, C, Rohde, S, et al. Endovascular stroke therapy: Tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome. Stroke. 2013; 44:1453–5.
Cannon, C P. Oral platelet glycoprotein IIb/IIIa receptor inhibitors – part I. Clinical Cardiology. 2003; 26:358–64.
Second, S I. Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes. Circulation. 2001; 103:1727–33.
Cannon, C P, McCabe, C H, Wilcox, R G, et al. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation. 2000; 102:149–56.
O’Neill, W W, Serruys, P, Knudtson, M, et al. Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE trial investigators. Evaluation of oral xemilofiban in controlling thrombotic events. New England Journal of Medicine. 2000; 342:1316–24.
Mousa, S A, Khurana, S, Forsythe, M S. Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: Differentiation among glycoprotein IIb/IIIa antagonists. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000; 20:1162–7.
The SYMPHONY investigators. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: A randomised trial. Sibrafiban versus aspirin to yield maximum protection from ischemic heart events post-acute coronary syndromes. Lancet. 2000; 355:337–45.
Chew, D P, Bhatt, D L, Sapp, S, Topol, E J. Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: A meta-analysis of phase III multicenter randomized trials. Circulation. 2001; 103:201–6.
Saw, J, Bajzer, C, Casserly, I P, et al. Evaluating the optimal activated clotting time during carotid artery stenting. American Journal of Cardiology. 2006; 97:1657–60.
Batchelor, W B, Mahaffey, K W, Berger, P B, et al. A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: The ATLAST trial. Journal of the American College of Cardiology. 2001; 38:1608–13.
Hassan, A E, Memon, M Z, Georgiadis, A L, et al. Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures. Neurocritical Care. 2011; 15:96–100.
Zidar, J P. Rationale for low-molecular weight heparin in coronary stenting. American Heart Journal. 1997; 134:S81–87.
McDougall, C G, Johnston, S C, Gholkar, A, et al. Bioactive versus bare platinum coils in the treatment of intracranial aneurysms: The MAPS (matrix and platinum science) trial. American Journal of Neuroradiology. 2014; 35:935–42.
Molyneux, A J, Clarke, A, Sneade, M, et al. Cerecyte coil trial: Angiographic outcomes of a prospective randomized trial comparing endovascular coiling of cerebral aneurysms with either cerecyte or bare platinum coils. Stroke. 2012; 43:2544–50.
Coley, S, Sneade, M, Clarke, A, et al. Cerecyte coil trial: Procedural safety and clinical outcomes in patients with ruptured and unruptured intracranial aneurysms. American Journal of Neuroradiology. 2012; 33:474–80.
Butteriss, D, Gholkar, A, Mitra, D, Birchall, D, Jayakrishnan, V. Single-center experience of cerecyte coils in the treatment of intracranial aneurysms: Initial experience and early follow-up results. American Journal of Neuroradiology. 2008; 29:53–5.
Kallmes, D F, Ding, Y H, Dai, D, et al. A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke. 2007; 38:2346–52.
Nelson, P K, Lylyk, P, Szikora, I, et al. The pipeline embolization device for the intracranial treatment of aneurysms trial. American Journal of Neuroradiology. 2011; 32:34–40.
De Vries, J, Boogaarts, J, Van Norden, A, Wakhloo, A K. New generation of flow diverter (surpass) for unruptured intracranial aneurysms: A prospective single-center study in 37 patients. Stroke. 2013; 44:1567–77.
Darsaut, T E, Bing, F, Makoyeva, A, et al. Flow diversion to treat aneurysms: The free segment of stent. Journal of Neurointerventional Surgery. 2013; 5:452–7.
Augsburger, L, Farhat, M, Reymond, P, et al. Effect of flow diverter porosity on intraaneurysmal blood flow. Klinische Neuroradiologie. 2009; 19:204–14.
Walcott, B P, Pisapia, J M, Nahed, B V, Kahle, K T, Ogilvy, C S. Early experience with flow diverting endoluminal stents for the treatment of intracranial aneurysms. Journal of Clinical Neuroscience. 2011; 18:891–4.
McAuliffe, W, Wycoco, V, Rice, H, et al. Immediate and midterm results following treatment of unruptured intracranial aneurysms with the pipeline embolization device. American Journal of Neuroradiology. 2012; 33:164–70.
Stabile, E, Salemme, L, Sorropago, G, et al. Proximal endovascular occlusion for carotid artery stenting: Results from a prospective registry of 1,300 patients. Journal of the American College of Cardiology. 2010; 55:1661–7.
Ang, L, Mahmud, E. Monitoring oral antiplatelet therapy: Is it justified? Therapeutic Advances in Cardiovascular Disease. 2008; 2:485–96.
Smith, J W, Steinhubl, S R, Lincoff, A M, et al. Rapid platelet-function assay: An automated and quantitative cartridge-based method. Circulation. 1999; 99:620–5.
Antman, E M, Wiviott, S D, Murphy, S A, et al. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A triton-timi 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction) analysis. Journal of the American College of Cardiology. 2008; 51:2028–33.
Steinhubl, S R, Talley, J D, Braden, G A, et al. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: Results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation. 2001; 103:2572–8.
Helena Laboratories. 2015
Simon, D I, Liu, C B, Ganz, P, et al. A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheterization and Cardiovascular Interventions. 2001; 52:425–32.
Mukherjee, D, Chew, D P, Robbins, M, et al. Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk. Journal of Thrombosis and Thrombolysis. 2001; 11:151–4.
Pandya, D J, Fitzsimmons, B F, Wolfe, T J, et al. Measurement of antiplatelet inhibition during neurointerventional procedures: The effect of antithrombotic duration and loading dose. Journal of Neuroimaging. 2010; 20:64–9.
Lee, D H, Arat, A, Morsi, H, et al. Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: A single-center experience. American Journal of Neuroradiology. 2008; 29:1389–94.
Hill, M D, Martin, R H, Mikulis, D, et al. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): A phase 2, randomised, double-blind, placebo-controlled trial. Lancet. Neurology. 2012; 11:942–50.
Qureshi, A I, Luft, A R, Sharma, M, et al. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II – clinical aspects and recommendations. Neurosurgery. 2000; 46:1360–75.
Qureshi, A I, Janardhan, V, Memon, M Z, et al. Initial experience in establishing an academic neuroendovascular service: Program building, procedural types, and outcomes. Journal of Neuroimaging. 2009; 19:72–9.
Silver, F L, Mackey, A, Clark, W M, et al. Safety of stenting and endarterectomy by symptomatic status in the carotid revascularization endarterectomy versus stenting trial (CREST). Stroke. 2011; 42:675–80.
Bonati, L H, Jongen, L M, Haller, S, et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: A substudy of the International Carotid Stenting Study (ICSS). Lancet. Neurology. 2010; 9:353–62.
Economopoulos, K P, Sergentanis, T N, Tsivgoulis, G, Mariolis, A D, Stefanadis, C. Carotid artery stenting versus carotid endarterectomy: A comprehensive meta-analysis of short-term and long-term outcomes. Stroke. 2011; 42:687–92.
Halliday, A, Mansfield, A, Marro, J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet. 2004; 363:1491–502.
Rothwell, P M, Eliasziw, M, Gutnikov, S A, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003; 361:107–16.
Yadav, J S, Wholey, M H, Kuntz, R E, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. New England Journal of Medicine. 2004; 351:1493–501.
Mas, J L, Chatellier, G, Beyssen, B, EVA-35 Investigators. Carotid angioplasty and stenting with and without cerebral protection: Clinical alert from the Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) Trial. Stroke. 2004; 35:e18–20.
Matsumura, J S, Gray, W, Chaturvedi, S, et al. Results of carotid artery stenting with distal embolic protection with improved systems: Protected Carotid Artery Stenting in Patients at High Risk for Carotid Endarterectomy (PROTECT) Trial. Journal of Vascular Surgery. 2012; 55:968–76.
Myla, S, Bacharach, J M, Ansel, G M, et al. Carotid artery stenting in high surgical risk patients using the fibernet embolic protection system: The EPIC trial results. Catheterization and Cardiovascular Interventions. 2010; 75:817–22.
Higashida, R T, Popma, J J, Apruzzese, P, Zimetbaum, P; MAVErIC I and II Investigators. Evaluation of the Medtronic exponent self-expanding carotid stent system with the Medtronic guardwire temporary occlusion and aspiration system in the treatment of carotid stenosis: Combined from the MAVErIC (Medtronic AVE self-expanding carotid stent system with distal protection in the treatment of carotid stenosis) I and MAVErIC II trials. Stroke. 2010; 41:e102–9.
Ansel, G M, Hopkins, L N, Jaff, M R, et al. Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: Results from the ARMOUR pivotal trial. Catheterization and Cardiovascular Interventions. 2010; 76:1–8.
Ohki, T, Parodi, J, Veith, F J, et al. Efficacy of a proximal occlusion catheter with reversal of flow in the prevention of embolic events during carotid artery stenting: An experimental analysis. Journal of Vascular Surgery. 2001; 33:504–9.
Harada, K, Kakumoto, K, Morioka, J, Saito, T, Fukuyama, K. Combination of flow reversal and distal filter for cerebral protection during carotid artery stenting. Annals of Vascular Surgery. 2014; 28:651–8.
Cano, M N, Kambara, A M, de Cano, S J, et al. Randomized comparison of distal and proximal cerebral protection during carotid artery stenting. Cardiovascular Interventions. 2013; 6:1203–9.
Stabile, E, Sannino, A, Schiattarella, G G, et al. Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: A meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion. Cardiovascular Interventions. 2014; 7:1177–83.
Bersin, R M, Stabile, E, Ansel, G M, et al. A meta-analysis of proximal occlusion device outcomes in carotid artery stenting. Catheterization and Cardiovascular Interventions. 2012; 80:1072–8.
Dalainas, I, Nano, G, Bianchi, P, et al. Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting. Cardiovascular and Interventional Radiology. 2006; 29:519–21.
McKevitt, F M, Randall, M S, Cleveland, T J, et al. The benefits of combined anti-platelet treatment in carotid artery stenting. European Journal of Vascular and Endovascular Surgery. 2005; 29:522–7.
Van Der Heyden, J, Van Werkum, J, Hackeng, C M, et al. High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: Results of the randomized IMPACT trial. Journal of Cardiovascular Surgery. 2013; 54:337–47.
Nakagawa, I, Wada, T, Park, H S, et al. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis. Journal of Vascular Surgery. 2014; 59:761–7.
Zahn, R, Ischinger, T, Hochadel, M, et al. Glycoprotein IIb/IIIa antagonists during carotid artery stenting: Results from the Carotid Artery Stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Clinical Research in Cardiology. 2007; 96:730–7.
Hofmann, R, Kerschner, K, Steinwender, C, et al. Abciximab bolus injection does not reduce cerebral ischemic complications of elective carotid artery stenting: A randomized study. Stroke. 2002; 33:725–7.
Qureshi, A I, Suri, M F, Ali, Z, et al. Carotid angioplasty and stent placement: A prospective analysis of perioperative complications and impact of intravenously administered abciximab. Neurosurgery. 2002; 50:466–73.
Walcott, B P, Gerrard, J L, Nogueira, R G, et al. Microsurgical retrieval of an endovascular microcatheter trapped during onyx embolization of a cerebral arteriovenous malformation. Journal of Neurointerventional Surgery. 2011; 3:77–9.
Huk, W, Becker, H. [Complication after embolization of an AVM with onyx]. Klinische Neuroradiologie. 2009; 19:145–52.
Chimowitz, M I, Lynn, M J, Derdeyn, C P, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. New England Journal of Medicine. 2011; 365:993–1003.
Siddiq, F, Chaudhry, S A, Khatri, R, et al. Rate of postprocedural stroke and death in SAMMPRIS trial-eligible patients treated with intracranial angioplasty and/or stent placement in practice. Neurosurgery. 2012; 71:68–73.
Qureshi, A I, Abou-Chebl, A, Jovin, T G. Qualification requirements for performing neurointerventional procedures: A report of the Practice Guidelines Committee of the American Society of Neuroimaging and the Society of Vascular and Interventional Neurology. Journal of Neuroimaging. 2008; 18:433–47.
References
Moniz, E. L’encéphalographie artérielle, son importance dans la localisation des tumeurs cérébrales. Revue Neurologique. 1927; 2:63.
Kaufmann, T J, Kallmes, D F. Diagnostic cerebral angiography: Archaic and complication-prone or here to stay for another 80 years? American Journal of Roentgenology. 2008; 190:1435–7.
Kallmes, D F, Layton, K, Marx, W F, Tong, F. Death by nondiagnosis: why emergent CT angiography should not be done for patients with subarachnoid hemorrhage. American Journal of Neuroradiology. 2007; 28:1837–8.
Dion, J E, Gates, P C, Fox, A J, Barnett, H J, Blom, R J. Clinical events following neuroangiography: a prospective study. Stroke. 1987; 18:997–1004.
Warnock, N G, Gandhi, M R, Bergvall, U, Powell, T. Complications of intraarterial digital subtraction angiography in patients investigated for cerebral vascular disease. British Journal of Radiology. 1993; 66:855–8.
Earnest, F T, Forbes, G, Sandok, B A, et al. Complications of cerebral angiography: prospective assessment of risk. American Journal of Roentgenology. 1984; 142:247–53.
Kaufmann, T J, Huston, J 3rd, Mandrekar, J N, et al. of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology. 2007; 243:812–19.
Olivecrona, H. Complications of cerebral angiography. Neuroradiology. 1977; 14:175–81.
Thiex, R, Norbash, A M, Frerichs, K U. et al. The safety of dedicated-team catheter-based diagnostic cerebral angiography in the era of advanced noninvasive imaging. American Journal of Neuroradiology. 2010; 31:230–4.
Willinsky, R A, Taylor, S M, TerBrugge, K, et al. Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology. 2003; 227:522–8.
Baum, S, Stein, G N, Kuroda, K K. Complications of “no arteriography”. Radiology. 1966; 86:835–8.
Dawkins, A A, Evans, A L, Wattam, J, et al. Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures. Neuroradiology. 2007; 49:753–9.
Mani, R L, Eisenberg, R L. Complications of catheter cerebral arteriography: analysis of 5,000 procedures. III. Assessment of arteries injected, contrast medium used, duration of procedure, and age of patient. American Journal of Roentgenology. 1978; 131:871–4.
Mani, R L, Eisenberg, R L. Complications of catheter cerebral arteriography: analysis of 5,000 procedures. II. Relation of complication rates to clinical and arteriographic diagnoses. American Journal of Roentgenology. 1978; 131:867–9.
Mani, R L, Eisenberg, R L, McDonald, E J Jr., Pollock, J A, Mani, J R. Complications of catheter cerebral arteriography: analysis of 5,000 procedures. I. Criteria and incidence. American Journal of Roentgenology. 1978; 131:861–5.
Waugh, J R, Sacharias, N. Arteriographic complications in the DSA era. Radiology. 1992; 182:243–6.
Pohler, E, Gunther, H, Diekmann, M, Eggeling, T. Outpatient coronary angiography–safety and feasibility. Cardiology. 1994; 84:305–9.
Cloft, H J, Joseph, G J, Dion, J E. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis. Stroke. 1999; 30:317–20.
Heiserman, J E, Dean, B L, Hodak, J A, et al. Neurologic complications of cerebral angiography. American Journal of Neuroradiology. 1994; 15:1401–7.
Dagirmanjian, A, Davis, D A, Rothfus, W E, Deeb, Z L, Goldberg, A L. Silent cerebral microemboli occurring during carotid angiography: frequency as determined with Doppler sonography. American Journal of Roentgenology. 1993; 161:1037–40.
Markus, H, Loh, A, Israel, D, et al. Microscopic air embolism during cerebral angiography and strategies for its avoidance. Lancet. 1993; 341:784–7.
Gerraty, R P, Bowser, D N, Infeld, B, Mitchell, P J, Davis, S M. Microemboli during carotid angiography. Association with stroke risk factors or subsequent magnetic resonance imaging changes? Stroke. 1996; 27:1543–7.
Mamourian, A, Drayer, B P. Clinically silent infarcts shown by MR after cerebral angiography. American Journal of Neuroradiology. 1990; 11:1084.
Bendszus, M, Koltzenburg, M, Burger, R, et al. Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study. Lancet. 1999; 354:1594–7.
Chuah, K C, Stuckey, S L, Berman, I G. Silent embolism in diagnostic cerebral angiography: detection with diffusion-weighted imaging. Australasian Radiology. 2004; 48:133–8.
Hahnel, S, Bender, J, Jansen, O, et al. [Clinically silent cerebral embolisms after cerebral catheter angiography]. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2001; 173:300–5.
Kato, K, Tomura, N, Takahashi, S, Sakuma, I, Watarai, J. Ischemic lesions related to cerebral angiography: Evaluation by diffusion weighted MR imaging. Neuroradiology. 2003; 45:39–43.
Krings, T, Willmes, K, Becker, R, et al. Silent microemboli related to diagnostic cerebral angiography: a matter of operator’s experience and patient’s disease. Neuroradiology. 2006; 48:387–93.
Bendszus, M, Koltzenburg, M, Bartsch, A J, et al. Heparin and air filters reduce embolic events caused by intra-arterial cerebral angiography: a prospective, randomized trial. Circulation. 2004; 110:2210–15.
Bendszus, M, Stoll, G. Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurology. 2006; 5:364–72.
Bendszus, M, Reents, W, Franke, D, et al. Brain damage after coronary artery bypass grafting. Archives of Neurology. 2002; 59:1090–5.
Knipp, S C, Matatko, N, Wilhelm, H, et al. Evaluation of brain injury after coronary artery bypass grafting. A prospective study using neuropsychological assessment and diffusion-weighted magnetic resonance imaging. European Journal of Cardio-Thoracic Surgery. 2004; 25:791–800.
Lund, C, Nes, R B, Ugelstad, T P, et al. Cerebral emboli during left heart catheterization may cause acute brain injury. European Heart Journal. 2005; 26:1269–75.
Lund, C, Sundet, K, Tennoe, B, et al. Cerebral ischemic injury and cognitive impairment after off-pump and on-pump coronary artery bypass grafting surgery. Annals of Thoracic Surgery. 2005; 80:2126–31.
Restrepo, L, Wityk, R J, Grega, M A, et al. Diffusion- and perfusion-weighted magnetic resonance imaging of the brain before and after coronary artery bypass grafting surgery. Stroke. 2002; 33:2909–15.
Brockmann, C, Hoefer, T, Diepers, M, et al. Abciximab does not prevent ischemic lesions related to cerebral angiography: a randomized placebo-controlled trial. Cerebrovascular Disease. 2011; 31:353–7.
Wolfe, T J, Hussain, S I, Lynch, J R, Fitzsimmons, B F, Zaidat, O O. Pediatric cerebral angiography: analysis of utilization and findings. Pediatric Neurology. 2009; 40:98–101.
Burger, I M, Murphy, K J, Jordan, L C, Tamargo, R J, Gailloud, P. Safety of cerebral digital subtraction angiography in children: complication rate analysis in 241 consecutive diagnostic angiograms. Stroke. 2006; 37:2535–9.
Hoffman, C E, Santillan, A, Rotman, L, Gobin, Y P, Souweidane, M M. Complications of cerebral angiography in children younger than 3 years of age: clinical article. Journal of Neurosurgery Pediatrics. 2014; 13:414–19.
References
Gottesman, R F, McKhann, G, Hogue, C V. Neurological complications of cardiac surgery. Semin Neurol. 2008; 703–15.
Karalis, D G, Quinn, V, Victor, M F, et al. Risk of catheter-related emboli in patients with atherosclerotic debris in the thoracic aorta. Am Heart J. 1996; 131(6):1149–55.
Eggebrecht, H, Oldenburg, O, Dirsch, O et al. Potential embolization by atherosclerotic debris dislodged from aortic wall during cardiac catheterization: histological and clinical findings in 7,621 patients. Catheter Cardiovasc Interv. 2000; 49(4):389–94.
Qureshi, A I, Luft, A R, Sharma, M, Guterman, L R, Hopkins, L N. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I – Pathophysiological and pharmacological features. Neurosurgery. 2000; 46(6):1344–59.
Hoffman, S J, Holmes, D R Jr, Rabinstein, A A, et al. Trends, predictors, and outcomes of cerebrovascular events related to percutaneous coronary intervention: A 16-year single-center experience. JACC Cardiovasc Interv. 2011; 4(4):415–22.
Lund, C, Nes, R B, Ugelstad, T P, et al. Cerebral emboli during left heart catheterization may cause acute brain injury. Eur Heart J. 2005; 26(13):1269–75.
Keeley, E C, Grines, C L. Scraping of aortic debris by coronary guiding catheters: A prospective evaluation of 1,000 cases. J Am Coll Cardiol. 1998; 32(7):1861–5.
Hilliard, A A, From, A M, Lennon, R J, et al. Percutaneous revascularization for stable coronary artery disease temporal trends and impact of drug-eluting stents. JACC Cardiovasc Interv. 2010; 3(2):172–9.
Dukkipati, S, O’Neill, W W, Harjai, K J, et al. Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol. 2004; 43(7):1161–7.
Aggarwal, A, Dai, D, Rumsfeld, J S, Klein, L W, Roe, M T. Incidence and predictors of stroke associated with percutaneous coronary intervention. Am J Cardiol. 2009; 104(3):349–53.
Hoffman, S J, Routledge, H C, Lennon, R J, et al. Procedural factors associated with percutaneous coronary intervention-related ischemic stroke. JACC Cardiovasc Interv. 2012; 5(2):200–6.
Cappato, R, Calkins, H, Chen, S A, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010; 3(1):32–8.
Maan, A, Shaikh, A Y, Mansour, M, Ruskin, J N, Heist, E K. Complications from catheter ablation of atrial fibrillation: a systematic review. Crit Pathw Cardiol. 2011; 10(2):76–83.
Haeusler, K G, Kirchhof, P, Endres, M. Left atrial catheter ablation and ischemic stroke. Stroke. 2012; 43(1):265–70.
Haeusler, K G, Koch, L, Herm, J, et al. 3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: results of the MACPAF study. J Cardiovasc Electrophysiol. 2013; 24(1):14–21.
Oral, H, Chugh, A, Ozaydin, M, et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation. 2006; 114(8):759–65.
Lemola, K, Desjardins, B, Sneider, M, et al. Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. Heart Rhythm. 2005; 2(9):923–8.
Di Biase, L, Burkhardt, J D, Mohanty, P, et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010; 121(23):2550–6.
Rastegar, R, Harnick, D J, Weidemann, P, et al. Spontaneous echo contrast videodensity is flow-related and is dependent on the relative concentrations of fibrinogen and red blood cells. J Am Coll Cardiol. 2003; 41(4):603–10.
Ren, J F, Marchlinski, F E, Callans, D J. Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J Am Coll Cardiol. 2004; 43(10):1861–7.
Ren, J F, Marchlinski, F E, Callans, D J, et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol. 2005; 16(5):474–7.
Handke, M, Harloff, A, Olschewski, M, Hetzel, A, Geibel, A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007; 357(22):2262–8.
Furlan, A J, Reisman, M, Massaro, J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012; 366(11):991–9.
Carroll, J D, Saver, J L, Thaler, D E, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013; 368(12):1092–100.
Meier, B, Kalesan, B, Mattle, H P, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013; 368(12):1083–91.
Dowson, A, Mullen, M J, Peatfield, R, et al. Migraine Intervention with STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008; 117(11):1397–404.
Khairy, P, O’Donnell, C P, Landzberg, M J. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review. Ann Intern Med. 2003; 139(9):753–60.
Ricotta, J J, Faggioli, G L, Castilone, A, Hassett, J M. Risk factors for stroke after cardiac surgery. J Vasc Surg. 1995; 21:359–64.
Roach, G W, Kanchuger, M, Mora-Mangano, C, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med. 1996; 335:1857–63.
Hogue, C W, Murphy, S F, Schechtman, K B, Davilla-Roman, V G. Risk factors for early or delayed stroke after cardiac surgery. Circulation. 1999; 100:642–7.
Almassi, G H, Sommers, T, Moritz, T E, et al. Stroke in cardiac surgical patients: determinants and outcome. Ann Thorac Surg. 1999; 68:391–8.
Tarakji, K G, Sabik, JF III, Bhudia, S K, Batzy, L H, Blackstone, E H. Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. JAMA. 2011; 305:381–90.
Selnes, O A, Gottesman, R F, Grega, M A, et al. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med. 2012; 366:250–7.
Raja, S G, Berg, G A. Impact of off-pump coronary artery bypass surgery on systemic inflammation: Current best available evidence. J Card Surg. 2007; 22:445–55.
Gottesman, R F, Sherman, P M, Grega, M A et al. Watershed strokes after cardiac surgery: diagnosis, etiology and outcome. Stroke. 2006; 37:2306–11.
Caplan, L R, Hennerici, M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol. 1998; 55:1475–82.
Hedberg, M, Boivie, P, Engström, K G. Early and late stroke after coronary surgery: An analysis of risk factors and the impact of short-term and long-term survival. Eur J Cardiothorac Surg. 2011; 40:379–87.
McKhann, G M, Grega, M A, Borowicz, L M Jr, Baumgartner, W A, Selnes, O A. Stroke and encephalopathy after cardiac surgery. An update. Stroke. 2006; 37:562–71.
Karkouti, K, Djalani, G, Borger, M A, et al. Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg. 2005; 80:1381–7.
Goto, T, Baba, T, Honma, K, et al. Magnetic resonance imaging findings and postoperative neurologic dysfunction in elderly patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2001; 72:137–42.
Selnes, O A, Gottesman, R F, Grega, M A, et al. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med. 2012; 366:250–7.
Shroyer, A L, Grower, F L, Hattler, B, et al. On-pump vs. off-pump coronary-artery bypass surgery. N Engl J Med. 2009; 361:1827–37.
Møller, C H, Perko, M J, Lund, J T, et al. No major differences in 30-day outcomes in high-risk patients randomized to off-pump vs. on-pump coronary bypass surgery. The Best Bypass Surgery Trial. Circulation. 2010; 121:498–504.
Nishijama, K, Horiguchi, M, Shizuta, S, et al. Temporal pattern of strokes after on-pump and off-pump coronary artery bypass graft surgery. Ann Thorac Surg. 2009; 87:1839–44.
Bouchard, D, Carrier, M, Demers, P, et al. Statins in combination with beta-blocker therapy reduces postoperative stroke after coronary artery bypass graft surgery. Ann Thorac Surg. 2011; 91:654–9.
Mangano, D T. Aspirin and mortality from coronary bypass surgery. N Engl J Med. 2002; 347:1309–17.
Leon, M B, Smith, C R, Mack, M, et al. Transcatheter aortic valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363:1597–607.
Smith, C R, Leon, M B, Mack, M J, et al. Transcatheter versus surgical aortic valve replacement in high-risk patients. N Engl J Med. 2011; 364:2187–98.
Thomas, M, Schymik, G, Walther, T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010; 122:62–9.
Walther, T, Kasimir, M T, Doss, M, et al. One-year interim follow-up of the TRAVERSE trial: the initial feasibility study for transapical aortic valve implantation. Eur J Cardiothorac Surg. 2010; 39:532–7.
Svenson, L G, Dewey, T, Kapadia, S, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg. 2008; 86:46–55.
Piazza, N, Grube, E, Gerckens, U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008; 4:242–9.
Petronio, A S, De Carlo, M, Bedogni, F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve Revalving system. Circ Cardiovasc Interv. 2010; 3:359–66.
Zahn, R, Gerckens, U, Grube, E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011; 32:198–204.
Arnold, M, Schulz-Heise, S, Achenbach, S, et al. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc Int. 2010; 3:1126–32.
Rodes-Cabau, J, Dumont, E, Boone, R H, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011; 57:18–28.
Kahlert, P, Al-Rashid, F, Döttger, P, et al. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation. 2012; 126:1245–55.
Reinsfelt, B, Wetsrelind, A, Ioanes, D, et al. Transcranial Doppler microembolic signals and serum evidence of brain injury during transcatheter aortic valve implantation. Acta Anaesthesiol Scand. 2012; 56:240–7.
Vermeer, S E, Prins, N D, den Heijer, T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003; 348:1215–22.
Ben-Dor, I, Pichard, A D, Satler, L F, et al. Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. J Am Coll Cardiol Intv. 2010; 3:1150–6.
O’Brien, S M, Shahain, D M, Filardo, G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 2-isolated valve surgery. Ann Thorac Surg. 2009; 88-S23-42.
Ferrari, E, Tozzi, P, Hurni, M, et al. Primary isolated aortic valve surgery in octogenarians. Eur J Cardiothorac Surg. 2010; 38:128–33.
Elbardissi, A W, Shekar, P, Couper, G S, Cohn, L H. Minimally invasive aortic valve replacement in octogenarian, high-risk, transcatheter aortic valve implantation candidates. J Thorac Cardiovasc Surg. 2010; 141:328–35.
Leon, M B, Piazza, N, Nikolsky, E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials. A consensus report from the valve academic research consortium. J Am Coll Cardiol. 2011; 57:253–69.
Daneault, B, Kirtane, A J, Kodali, S K, et al. Stroke associated with surgical and transcatheter treatment of aortic stenosis. J Am Coll Cardiol. 2011; 58:2143–50.
Drews, T, Pasic, M, Bus, S, et al. Transcranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac Cardiovasc Surg. 2011; 59:237–42.
van der Linden, J, Casimir-Ahn, H. When do cerebral emboli appear during open heart operation? A Transcranial Doppler study. Ann Thorac Surg. 1991; 51:237–41.
Guerrieri Wolf, L, Choudhary, B P, Abu-Omar, Y, Taggert, D P. Solid and gaseous cerebral microembolization after biologic and mechanical aortic valve replacement: investigation with multirange and multifrequency transcranial Doppler ultrasound. J Thorac Cardiovasc Surg. 2008; 135:512–20.
Filsoufi, F, Rahmanian, P B, Castillo, J G, Bronster, D, Adams, D H. Incidence, imaging analysis, and early and late outcomes of stroke after cardiac valve operation. Am J Cardiol. 2008; 101:1472–8.
Sharony, R, Grossi, E A, Saunders, P C, et al. Aortic valve replacement in patients with impaired ventricular function. Ann Thorac Surg. 2003; 75:1808–14.
Ruel, M, Masters, R G, Rubens, F D, et al. Late incidence and determinants of stroke after aortic and mitral valve replacement. Ann Thorac Surg. 2004; 78:77–84.
Sundt, T M, Bailey, M S, Moon, M R, et al. Quality of life after aortic valve replacement at the age of >80 years. Circulation. 2000; 102:III70–4.
Alexander, K P, Anstrom, K J, Muhlbaier, L H, et al. Outcomes of cardiac surgery in patients > or = 80 years: Results from the National Cardiovascular Network. J Am Coll Cardiol. 2000; 35:731–8.
Naylor, A R, Mehta, Z, Rothwell, P M, Bell, P R. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg. 2002; 23:283–94.
Li, Y, Walicki, D, Mathiesen, C, Jenny, D, et al. Strokes after cardiac surgery and relationship to carotid stenosis. Arch Neurol. 2009; 66:1091–6.
Naylor, A R. Does the risk of post-CABG stroke merit staged or synchronous reconstruction in patients with symptomatic or asymptomatic carotid disease? J Cardiovasc Surg. 2009; 50:71–81.
Timaran, C H, Rosero, E B, Smith, S T, et al. Trends and outcomes of concurrent carotid revascularization and coronary bypass. J Vasc Surg. 2008; 48:355–61.
Knipp, S C, Scherag, A, Beyersdorf, F, et al. for the CABACS study group. Randomized comparison of synchronous CABG and carotid endarterectomy vs. isolated CABG in patients with asymptomatic carotid stenosis: The CABACS trial. Int J Stroke. 2012; 7:354–60.
References
Eastcott, H H G, Pickering, G W, Rob, C G. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet. 1954; ii:954.
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991; 325:445–53.
European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998; 351:1379–87.
Barnett, H J, Taylor, D W, Eliasziw, M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998; 339:1415–25.
Executive Committee of the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995; 273:1421–8.
Ferguson, G G, Eliasziw, M, Barr, H W, et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke. 1999; 30:1751–8.
Chaturvedi, S, Aggarwal, R, Murugappan, A. Results of carotid endarterectomy with prospective neurologist follow-up. Neurology. 2000; 26:55:769–72.
Spencer, M P. Transcranial Doppler monitoring and causes of stroke from carotid endarterectomy. Stroke. 1997; 28:685–91.
Huibers, A, Calvet, D, Kennedy, F, et al. Mechanism of procedural stroke following carotid endarterectomy or carotid artery stenting within the International Carotid Stenting Study (ICSS) randomised trial. Eur J Vasc Endovasc Surg. 2015; doi:10.1016/j.ejvs.2015.05.017. [Epub ahead of print].
Sundt, T M. The ischemic tolerance of neural tissue and the need for monitoring and selective shunting during carotid endarterectomy. Stroke. 1983; 14:93–8.
Sharbrough, F M, Messik, J M, Sundt, T M. Correlation of continuous electroencephalograms with cerebral blood flow measurements during carotid endarterectomy. Stroke. 1973; 4:674–83.
Blackshear, W M, Di Carlo, V, Seifert, K B, Connar, R G. Advantages of continuous electroencephalographic monitoring during carotid surgery. J Cardiovasc Surg. 1986; 27:146–53.
Cho, I, Smullens, S N, Streletz, L J, Fariello, R G. The value of intraoperative EEG monitoring during carotid endarterectomy. Ann Neurol. 1986; 20:508–12.
Blume, W T, Ferguson, G G, McNeil, D K. Significance of EEG changes at carotid endarterectomy. Stroke. 1986; 17:891–97.
McCarthy, W J, Park, A E, Koushanpour, E, et al. Carotid endarterectomy. Lessons from intraoprative monitoring – a decade of experience. Ann Surg. 1996; 224:291–307.
Balotta, E, Daigau, G, Saladini, M, et al. Results of electroencephalographic monitoring during 369 consecutive carotid artery revascularizations. Eur Neurol. 1997; 37:43–7.
Kearse, L A, Brown, E N, McPeck, K. Somatosensory evoked potential sensitivity relative to electroencephalography for cerebral ischemia during carotid endarterectomy. Stroke. 1992; 23:498–505.
Haupt, W F, Horsch, S. Evoked potential monitoring in carotid surgery: A review of 994 cases. Neurology. 1992; 42:835–8.
Duncan, L A, Ruckley, C V, Wildsmith, J A W. Cerebral oximetry: a useful monitor during carotid artery surgery. Anesthesiology. 1995; 50:1041–5.
Samra, S K, Dorje, P, Zelenock, G B, Stanley, J C. Cerebral oximetry in patients undergoing carotid endarterectomy under regional anesthesia. Stroke. 1996; 27:49–55.
Cherry, K J, Roland, C F, Hallett, J W, et al. Stump pressure, the contralateral carotid artery, and electroencephalographic changes. Am J Surg. 1991; 162:185–9.
Harada, R N, Comerota, A J, Good, G M, et al. Stump pressure, electroencephalographic changes, and the contralateral carotid artery: another look at selective shunting. Am J Surg. 1995; 170:148–53.
Benjamin, M E, Silva, M B, Watt, C, et al. Awake patient monitoring to determine the need for shunting during carotid endarterectomy. Surgery. 1993; 114:673–81.
Padayachee, T S, Bishop, C C R, Gosling, R G, et al. Monitoring middle cerebral artery blood flow velocity during carotid endarterectomy. Br J Surg. 1986; 73:98–100.
Steiger, H J, Schaffler, L, Boll, J, Liechti, S. Results of microsurgical carotid endarterectomy: a prospective study with transcranial Doppler and EEG monitoring, and selective shunting. Acta Neurochir. 1989; 100:31–8.
Spencer, M P, Thomas, G I, Nicholls, S C, Sauvage, L R. Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography. Stroke. 1990; 21:415–23.
Ackerstaff, R G A, Janes, C, Moll, F L, et al. The significance of emboli detection by means of transcranial Doppler ultrasonography monitoring in carotid endarterectomy. J Vasc Surg. 1995; 21:415–23.
Canthelmo, N L, Babikian, V L, Samaraweera, R N, et al. Cerebral microembolism and ischemic changes associated with carotid endarterectomy. J Vasc Surg. 1998; 27:1024–31.
Arnold, M, Sturzenegger, M, Schaffler, L, Seiler, R. Continuous intraoperative monitoring of middle cerebral artery flow velocities and electroencephalography during carotid endarterectomy. Stroke. 1997; 28:1345–50.
Spencer, M P. Transcranial Doppler monitoring and causes of stroke from carotid endarterectomy. Stroke. 1997; 28:685–91.
Jansen, C, Ramos, L M, van Heesewijk, J P, et al. Impact of microembolism and hemodynamic changes in the brain during carotid endarterectomy. Stroke. 1994; 25:992–7.
Ackerstaff, R G, Moons, K G, van de Vlasakker, C J, et al. Association of intraoperative transcranial Doppler monitoring variables with stroke from carotid endarterectomy. Stroke. 2000; 31:1817–23.
Babikian, V L, Canthelmo, N L. Cerebrovascular monitoring during carotid endarterectomy. Stroke. 2000; 31:1799–801.
Levy, C R, O’Malley, H M, Fell, G, et al. Transcranial Doppler detected cerebral microembolism following carotid endarterectomy. High intensity signal loads predict postoperative cerebral ischemia. Brain. 1997; 120:621–9.
Kaposzta, Z, Baskerville, P A, Madge, D, et al. L-arginine and S-nitrosoglutathione reduce embolization in humans. Circulation. 2001; 103:2371–5.
Chen, C I, Iguchi, Y, Garami, Z, et al. Analysis of emboli during carotid stenting with distal protection device. Cerebrovasc Dis. 2006; 21(4):223–8.
Zhou, W, Hitchner, E, Gillis, K, et al. Prospective neurocognitive evaluation of patients undergoing carotid interventions. J Vasc Surg. 2012; 56:1571–8.
Garami, Z, Lumsden, A B. Intra-operative and peri-procedural TCD monitoring. In Alexandrov, A V (ed). Cerebrovascular Ultrasound in Stroke Prevention and Treatment (2nd edn). Oxford: Wiley-Blackwell Publishers. 2011.
Garami, Z, Charlton-Ouw, K M, Broadbent, K C, Lumsden, A B. A practical guide to transcranial Doppler monitoring during carotid interventions. Part 1: basics and blood flow changes. Vascular Ultrasound Today. 2008; 13(1).
Gupta, N, Corriere, M A, Dodson, T F, et al. Incidence of microemboli to the brain is less with endarterectomy than with percutaneous revascularization with distal filters or flow reversal. J Vasc Surg. 2011; 53:316–22.
Pennekamp, C W, Moll, F L, De Borst, G J. Role of transcranial Doppler in cerebral hyperperfusion syndrome. J Cardiovasc Surg. 2012; 53:765–71.